Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Metin Gorguner

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
The Eurasian Journal of Medicine|January 23, 2015
Stereological Evaluation of Tumor Regression Rates in Lung Cancer Using CT Via the Cavalieri MethodMetin Akgun, Mecit Kantarci, Kerim Cayir, et al.
The Clinical Respiratory Journal|April 12, 2014
Frequency of Class I and II HLA alleles in patients with lung cancer according to chemotherapy response and 5-year survivalOmer Araz, Elif Yilmazel Ucar, Mehmet Meral, et al.
Respirology (Carlton, Vic.)|September 2, 2005
A prospective, multicentre clinical trial comparing cisplatin plus gemcitabine with cisplatin plus etoposide in patients with locally advanced and metastatic non-small cell lung cancerTuncay Goksel, Osman Nuri Hatipoglu, Can Ozturk, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
The Eurasian Journal of Medicine|January 23, 2015
Stereological Evaluation of Tumor Regression Rates in Lung Cancer Using CT Via the Cavalieri MethodMetin Akgun, Mecit Kantarci, Kerim Cayir, et al.
The Clinical Respiratory Journal|April 12, 2014
Frequency of Class I and II HLA alleles in patients with lung cancer according to chemotherapy response and 5-year survivalOmer Araz, Elif Yilmazel Ucar, Mehmet Meral, et al.
Respirology (Carlton, Vic.)|September 2, 2005
A prospective, multicentre clinical trial comparing cisplatin plus gemcitabine with cisplatin plus etoposide in patients with locally advanced and metastatic non-small cell lung cancerTuncay Goksel, Osman Nuri Hatipoglu, Can Ozturk, et al.
Pageof 3